Which has the lower trailing P/E, ALL or CRI?

ALL has the lower trailing P/E: ALL trades at 5.07 and CRI at 5.54. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ALL or CRI?

Over the past five years, ALL grew revenue faster — ALL at a 7.68% CAGR versus CRI at -2.54%.

Does ALL or CRI pay a bigger dividend?

ALL yields 1.68% and CRI yields 3.31% based on trailing dividends and the latest price.

Is ALL or CRI more profitable?

ALL runs the higher net margin — ALL at 19.24% versus CRI at 6.55%.

How have ALL and CRI total returns compared?

Over the past 10 years, ALL delivered 16.52% and CRI delivered -8.33% annualized total return. Past performance doesn't predict future results.

The Allstate Corporation (ALL) vs Carter's Inc. (CRI)

A side-by-side comparison of The Allstate Corporation and Carter's Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

Different business models: ALL is classified in Financial Services; CRI is classified in Consumer Cyclical. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

ALL

The Allstate Corporation

$65.31B

$253.71Financial ServicesDelayed quote: Sep 11, 2026, 4:00 PM EDT

CRI

Carter's Inc.

$1.12B

$30.43Consumer CyclicalDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ALL vs CRI

growth of $100 · dividends reinvested · last 10y

ALL +351.5% (+16.3%/yr)CRI -59.2% (-8.6%/yr)ALL compounded faster over this window

Log scale — wide-divergence pair

ALL CRI

ALL vs CRI: by the numbers

•ALL is the larger company ($65.31B vs $1.12B market cap).
•ALL trades at the lower trailing earnings multiple (5.07 vs 5.54 P/E), one valuation lens rather than an overall verdict.
•ALL converts more revenue to profit (19.24% vs 6.55% net margin).
•ALL grew revenue faster over the past five years (7.68% vs -2.54% CAGR).
•CRI pays the higher dividend yield (3.31% vs 1.68%).

Metrics side by side

Valuation

Metric	ALL	CRI
P/E ratio	5.07	5.54
Forward P/E	7.18	9.30
P/S ratio	0.94	0.38
P/B ratio	1.94	1.09
EV / EBITDA	N/A	5.00
FCF yield	N/A	26.13%

Profitability

Metric	ALL	CRI
Gross margin	33.23%	48.60%
Operating margin	24.83%	9.24%
Net margin	19.24%	6.55%
ROE	39.49%	18.99%
ROIC	N/A	10.17%

Dividends

Metric	ALL	CRI
Dividend yield	1.68%	3.31%
Payout ratio	8.47%	18.21%

Growth (annualized)

Metric	ALL	CRI
Revenue CAGR (5Y)	7.68%	-2.54%
EPS CAGR (5Y)	17.15%	-24.12%
FCF CAGR (5Y)	N/A	-26.11%
Total return CAGR (5Y)	16.59%	-18.44%

Frequently asked

Which has the lower trailing P/E, ALL or CRI?: ALL has the lower trailing P/E: ALL trades at 5.07 and CRI at 5.54. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ALL or CRI?: Over the past five years, ALL grew revenue faster — ALL at a 7.68% CAGR versus CRI at -2.54%.
Does ALL or CRI pay a bigger dividend?: ALL yields 1.68% and CRI yields 3.31% based on trailing dividends and the latest price.
Is ALL or CRI more profitable?: ALL runs the higher net margin — ALL at 19.24% versus CRI at 6.55%.
How have ALL and CRI total returns compared?: Over the past 10 years, ALL delivered 16.52% and CRI delivered -8.33% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ALL analysis Full CRI analysis Interactive comparison tool

Dig into the metrics

Allstate P/E ratio Carter's P/E ratio Allstate dividend yield Carter's dividend yield Allstate ROE Carter's ROE Allstate operating margin Carter's operating margin Allstate revenue growth Carter's revenue growth Carter's free cash flow

Allstate & Carter's appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.